Shi Yang, MD Hear my name
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine
Anatomic Pathology

MM, Hebei Medical College
MB, China Academy of Chinese Medical Sciences (CACMS)
BS, Hebei Medical College

Pronouns: he/him/his

Expertise in molecular pathology.

Diversity, Equity, Inclusion and Accessibility

I am fully for diversity equity inclusion and accessibility (DEIA not only for supporting the idea but also showed the action that I am for it, support and do it. I believe these action and activities can build a better society and better BU.
I came along from a different country and culture environment to pursue a better career in medicine and research. Throughout 30 plus years training and working of my life at BUSM, I am better understood, equipped and benefit from practicing DEIA.
As a result, I actively engaged in DEIA activities and supporting the movement by my own action. In addition of doing everything helpful in my everyday activity, I also participate in network activities in groups like FSCN (faculty and staff of color community network: I am the treasurer of BU FSCN). I believe action is much more active and efficient than words along. I will consistently do what I thought was the right thing throughout my tenure of Boston University and beyond.

Boston University
BU-BMC Cancer Center

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Yang S, Leone DA, Biswas A, Deng A, Jukic D, Singh R, Sundram U, Mahalingam M. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Hum Pathol. 2018 12; 82:206-214. PMID: 30120967
  2. de la Cueva A, Emmerling M, Lim SL, Yang S, Trackman PC, Sonenshein GE, Kirsch KH. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer. Carcinogenesis. 2018 07 03; 39(7):921-930.View Related Profiles. PMID: 29579155; PMCID: PMC6692853; DOI: 10.1093/carcin/bgy045;
  3. Alekseyev YO, Fazeli R, Yang S, Basran R, Maher T, Miller NS, Remick D. A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? Acad Pathol. 2018 Jan-Dec; 5:2374289518766521.View Related Profiles. PMID: 29761157; PMCID: PMC5944141; DOI: 10.1177/2374289518766521;
  4. Frydenlund N, Leone D, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Singh R, Biswas A, Yaar R, Mahalingam M. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant. Mod Pathol. 2017 Mar; 30(3):357-369. PMID: 28084337; DOI: 10.1038/modpathol.2016.210;
  5. Josenia Tan, Antonio de las Morenas , Shi Yang and Huihong Xu. Comparison of the clinicopathologic features of solitary and multifocal papillary thyroid carcinoma and the utility of testing an additional tumor nodule for BRAFV600E in multifocal cases. J Mod Hum Pathol. 2017; 2(1):1-6. View Publication
  6. Mitchell B, Leone D, Yang S, Khan A, Mahalingam M, Dhingra J. BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin? Am J Transl Res. 2016; 8(11):5076-5086. PMID: 27904709; PMCID: PMC5126351
  7. Yang S, Leone D, Frydenlund N, Hoang M, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res. 2016 Aug; 26(4):361-6. PMID: 27244099; DOI: 10.1097/CMR.0000000000000272;
  8. Kadokura A, Frydenlund N, Leone DA, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Hum Pathol. 2016 Jul; 53:82-90. PMID: 26980030; DOI: 10.1016/j.humpath.2016.02.012;
  9. Mitchell B, Leone DA, Feller JK, Yang S, Mahalingam M. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin? Hum Pathol. 2016 Jun; 52:19-27. PMID: 26980024; DOI: 10.1016/j.humpath.2015.12.030;
  10. Chung HJ, Yang S, Succaria F, Bhawan J. Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas. J Am Acad Dermatol. 2015 Nov; 73(5):864-5.View Related Profiles. PMID: 26475538; DOI: 10.1016/j.jaad.2015.07.030;
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 52 publications over 22 distinct years, with a maximum of 6 publications in 2014


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Cancer Research: GI Cancer/Breast Cancer/Melanoma
Diagnostic Molecular Pathology
Member of AMP
Member of ASCB
Member of USCAP
Contact for Mentoring:

670 Albany St Biosquare III
Boston MA 02118
Google Map

Yang's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department